RecruitingPhase 3

Better Evidence and Translation for Calciphylaxis

Australia350 participantsStarted 2021-08-26

Plain-language summary

This global platform study will evaluate multiple interventions, across several domains of therapeutic care, in adult patients with kidney failure and newly diagnosed calciphylaxis.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Currently receiving haemodialysis, or peritoneal dialysis that can be converted to haemodialysis, with planned ongoing haemodialysis a minimum of three times per week for at least the duration of the protocolised calciphylaxis treatments within this trial
✓. Have a new calciphylaxis ulcer present for less than 10 weeks
✓. Age ≥ 18 years
✓. Eligible for randomisation in at least one recruiting domain
✓. The participant and treating physician are willing and able to perform trial procedures

What they're measuring

BEAT-Calci Wound Assessment Scale (BCWAS) - Baseline to Week 12

Timeframe: Week 12

Trial details

NCT IDNCT05018221

SponsorUniversity of Sydney

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-12

Contact for this trial

Sibyl Masterman

8036 5272 sibyl.masterman@sydney.edu.au

View on ClinicalTrials.gov More Calciphylaxis trials